Companies Partner With Goal of Treating PF, Other Fibrotic Disorders

Companies Partner With Goal of Treating PF, Other Fibrotic Disorders

310161

Companies Partner With Goal of Treating PF, Other Fibrotic Disorders

Oncodesign and TiumBio have partnered to develop therapies for various diseases caused by fibrosis, or tissue scarring, including pulmonary fibrosis (PF). Under the collaboration, the French company Oncodesign will identify, produce, optimize, and conduct early stage analysis of therapeutic candidates generated from Nanocyclix — a technology platform designed to enhance the potency and selectivity of small molecules that target and block enzymes called kinases. TiumBio, based in South Korea, will be responsible for assessing the…

You must be logged in to read/download the full post.